Skip to main content
Clinical Trials/IRCT20221230056986N1
IRCT20221230056986N1
Not yet recruiting
Phase 2

Effectiveness of unified protocol of transdiagnostic treatment on psychological symptoms, fatigue, emotion regulation, health anxiety, sleep quality, and sexual satisfaction in patients with multiple sclerosis

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Multiple Sclerosis.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
48
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Confirmation of relapsing\-remitting multiple sclerosis diagnosis by neurologist
  • Age least 20 years
  • Being sexually active
  • Mastery in Persian language and reading and writing literacy
  • Fixed dosage of medicine from 3 months before beginning the treatment
  • Being physically able to participate in weekly sessions
  • Not being diagnosed with severe psychiatric disorders
  • Not being diagnosed with another serious or chronic physical illness
  • Not having the history of receiving psychological treatments

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials